Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.620
+0.070 (1.54%)
At close: Nov 21, 2025, 4:00 PM EST
4.710
+0.090 (1.95%)
After-hours: Nov 21, 2025, 5:51 PM EST
Nyxoah Revenue
Nyxoah had revenue of 1.97M EUR in the quarter ending September 30, 2025, with 55.77% growth. This brings the company's revenue in the last twelve months to 5.64M, up 10.96% year-over-year. In the year 2024, Nyxoah had annual revenue of 4.52M with 3.98% growth.
Revenue (ttm)
5.64M EUR
Revenue Growth
+10.96%
P/S Ratio
26.23
Revenue / Employee
30,714 EUR
Employees
184
Market Cap
173.56M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.52M | 173.00K | 3.98% |
| Dec 31, 2023 | 4.35M | 1.26M | 40.99% |
| Dec 31, 2022 | 3.08M | 2.23M | 261.97% |
| Dec 31, 2021 | 852.00K | 783.00K | 1,134.78% |
| Dec 31, 2020 | 69.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NYXH News
- 2 days ago - Information on the total number of voting rights and shares - GlobeNewsWire
- 9 days ago - Nyxoah SA (NYXH) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio - GlobeNewsWire
- 9 days ago - Nyxoah Reports Third Quarter 2025 Financial and Operating Results - GlobeNewsWire
- 19 days ago - Nyxoah to Participate in the Stifel 2025 Healthcare Conference - GlobeNewsWire
- 23 days ago - Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025 - GlobeNewsWire
- 6 weeks ago - Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System - GlobeNewsWire
- 7 weeks ago - Publication relating to transparency notifications - GlobeNewsWire